We bring academic leadership, credibility, inspiration combined with operational excellence to global clinical trial research.
Julius Clinical offers a unique combination of an academic research organization and a clinical research organization. An extensive range of services is provided that can be tailored to meet the needs of (pharmaceutical) partners. A ‘one-size-fits-all’ approach is rejected, in favor of one based on flexibility, creativity, and innovation.
Julius Clinical has completed over 50 trials with expertise covering both investigator-initiated and industry-sponsored trials. Over 130.000 patients have been enrolled across 30 countries worldwide, involving innovative pharmaceuticals in a broad range of therapeutic areas, including infectious diseases, cardiovascular diseases, metabolic diseases and central nervous system (CNS) diseases.